Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome

Authors: Carla L Ellis, Rebecca L Manno, John P Havill, Lorraine C Racusen, Duvuru Geetha

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Renal biopsies provide important diagnostic and prognostic information in ANCA associated glomerulonephritis. A new classification for prognostication of pauci-immune glomerulonephritis (GN) based on four categories (Mixed, Crescentic, Sclerotic and Focal) was proposed by an international working group of renal pathologists (IWGRP). The goal of our study was to apply the proposed classification system to a United States cohort of vasculitis patients and determine the association of IWGRP class with estimated glomerular filtration rate (eGFR) at one year.

Methods

Seventy-six cases of pauci-immune glomerulonephritis diagnosed from 1995 to 2011 from a single center were identified for this retrospective study. Clinical data were collected by abstraction from medical records. Histology was reviewed by a pathologist and classified according to the new classification. MDRD formula was used to calculate eGFR. We correlated IWGRP class to renal function at presentation and at one year. ×2, ANOVA, and linear regression analysis were performed as appropriate.

Results

Renal biopsies were categorized as focal: n = 20, crescentic: n = 18, mixed: n = 27, sclerotic: n = 11. The baseline e-GFR was lowest in the crescentic class and highest in the focal class. In linear regression analysis investigating e-GFR at 1 year; age and baseline e-GFR were independent predictors of e-GFR at 1 year.

Conclusions

The e-GFR at diagnosis and age were predictors of e-GFR at 1 year. Pathologic class at diagnosis may also be a helpful tool in risk stratification at diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR: Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003, 41 (4): 776-784. 10.1016/S0272-6386(03)00025-8.CrossRefPubMed Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR: Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003, 41 (4): 776-784. 10.1016/S0272-6386(03)00025-8.CrossRefPubMed
2.
go back to reference Falk RJ, Nachman PH, Hogan SL, Jennette JC: ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol. 2000, 20 (3): 233-243.PubMed Falk RJ, Nachman PH, Hogan SL, Jennette JC: ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin Nephrol. 2000, 20 (3): 233-243.PubMed
3.
go back to reference Cohen BA, Clark WF: Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. Am J Kidney Dis. 2000, 36 (5): 914-924. 10.1053/ajkd.2000.19082.CrossRefPubMed Cohen BA, Clark WF: Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy. Am J Kidney Dis. 2000, 36 (5): 914-924. 10.1053/ajkd.2000.19082.CrossRefPubMed
4.
go back to reference Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med. 1997, 337 (21): 1512-1523. 10.1056/NEJM199711203372106.CrossRefPubMed Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med. 1997, 337 (21): 1512-1523. 10.1056/NEJM199711203372106.CrossRefPubMed
5.
go back to reference Harris AA, Falk RJ, Jennette JC: Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis. 1998, 32 (1): 179-184.CrossRefPubMed Harris AA, Falk RJ, Jennette JC: Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis. 1998, 32 (1): 179-184.CrossRefPubMed
6.
go back to reference Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, De Groot K, et al: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003, 349 (1): 36-44. 10.1056/NEJMoa020286.CrossRefPubMed Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, De Groot K, et al: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003, 349 (1): 36-44. 10.1056/NEJMoa020286.CrossRefPubMed
7.
go back to reference Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, et al: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007, 18 (7): 2180-2188. 10.1681/ASN.2007010090.CrossRefPubMed Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, et al: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007, 18 (7): 2180-2188. 10.1681/ASN.2007010090.CrossRefPubMed
8.
go back to reference Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005, 143 (9): 621-631. 10.7326/0003-4819-143-9-200511010-00005.CrossRefPubMed Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005, 143 (9): 621-631. 10.7326/0003-4819-143-9-200511010-00005.CrossRefPubMed
9.
go back to reference Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003, 63 (2): 670-677. 10.1046/j.1523-1755.2003.00769.x.CrossRefPubMed Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003, 63 (2): 670-677. 10.1046/j.1523-1755.2003.00769.x.CrossRefPubMed
10.
go back to reference Aasarod K, Bostad L, Hammerstrom J, Jorstad S, Iversen BM: Renal histopathology and clinical course in 94 patients with Wegener’s granulomatosis. Nephrol Dial Transplant. 2001, 16 (5): 953-960. 10.1093/ndt/16.5.953.CrossRefPubMed Aasarod K, Bostad L, Hammerstrom J, Jorstad S, Iversen BM: Renal histopathology and clinical course in 94 patients with Wegener’s granulomatosis. Nephrol Dial Transplant. 2001, 16 (5): 953-960. 10.1093/ndt/16.5.953.CrossRefPubMed
11.
go back to reference Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 1999, 56 (5): 1751-1758. 10.1046/j.1523-1755.1999.00758.x.CrossRefPubMed Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 1999, 56 (5): 1751-1758. 10.1046/j.1523-1755.1999.00758.x.CrossRefPubMed
12.
go back to reference de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noel LH, Ferrario F, Waldherr R, Hagen EC: Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006, 17 (8): 2264-2274. 10.1681/ASN.2005080870.CrossRefPubMed de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noel LH, Ferrario F, Waldherr R, Hagen EC: Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006, 17 (8): 2264-2274. 10.1681/ASN.2005080870.CrossRefPubMed
13.
go back to reference Hauer HA, Bajema IM, Hagen EC, Noel LH, Ferrario F, Waldherr R, Van Houwelingen HC, Lesavre P, Sinico RA, van der Woude F, et al: Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant. 2002, 17 (4): 587-596. 10.1093/ndt/17.4.587.CrossRefPubMed Hauer HA, Bajema IM, Hagen EC, Noel LH, Ferrario F, Waldherr R, Van Houwelingen HC, Lesavre P, Sinico RA, van der Woude F, et al: Long-term renal injury in ANCA-associated vasculitis: an analysis of 31 patients with follow-up biopsies. Nephrol Dial Transplant. 2002, 17 (4): 587-596. 10.1093/ndt/17.4.587.CrossRefPubMed
14.
go back to reference Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC: Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002, 62 (5): 1732-1742. 10.1046/j.1523-1755.2002.00605.x.CrossRefPubMed Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC: Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int. 2002, 62 (5): 1732-1742. 10.1046/j.1523-1755.2002.00605.x.CrossRefPubMed
15.
go back to reference Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT: Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant. 2005, 20 (1): 96-104. 10.1093/ndt/gfh563.CrossRefPubMed Neumann I, Kain R, Regele H, Soleiman A, Kandutsch S, Meisl FT: Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant. 2005, 20 (1): 96-104. 10.1093/ndt/gfh563.CrossRefPubMed
16.
go back to reference Vergunst CE, Van Gurp E, Hagen EC, Van Houwelingen HC, Hauer HA, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, et al: An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis. 2003, 41 (3): 532-538. 10.1053/ajkd.2003.50115.CrossRefPubMed Vergunst CE, Van Gurp E, Hagen EC, Van Houwelingen HC, Hauer HA, Noel LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA, et al: An index for renal outcome in ANCA-associated glomerulonephritis. Am J Kidney Dis. 2003, 41 (3): 532-538. 10.1053/ajkd.2003.50115.CrossRefPubMed
17.
go back to reference Haroun MK, Stone JH, Nair R, Racusen L, Hellmann DB, Eustace JA: Correlation of percentage of normal glomeruli with renal outcome in Wegener’s granulomatosis. Am J Nephrol. 2002, 22 (5–6): 497-503.CrossRefPubMed Haroun MK, Stone JH, Nair R, Racusen L, Hellmann DB, Eustace JA: Correlation of percentage of normal glomeruli with renal outcome in Wegener’s granulomatosis. Am J Nephrol. 2002, 22 (5–6): 497-503.CrossRefPubMed
18.
go back to reference Kapitsinou PP, Ioannidis JP, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM: Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis. 2003, 41 (1): 29-37. 10.1053/ajkd.2003.50013.CrossRefPubMed Kapitsinou PP, Ioannidis JP, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM: Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis. 2003, 41 (1): 29-37. 10.1053/ajkd.2003.50013.CrossRefPubMed
19.
go back to reference Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noel LH, Pusey CD, Waldherr R: Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010, 21 (10): 1628-1636. 10.1681/ASN.2010050477.CrossRefPubMed Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noel LH, Pusey CD, Waldherr R: Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010, 21 (10): 1628-1636. 10.1681/ASN.2010050477.CrossRefPubMed
20.
go back to reference Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37 (2): 187-192. 10.1002/art.1780370206.CrossRefPubMed Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37 (2): 187-192. 10.1002/art.1780370206.CrossRefPubMed
21.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130 (6): 461-470. 10.7326/0003-4819-130-6-199903160-00002.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130 (6): 461-470. 10.7326/0003-4819-130-6-199903160-00002.CrossRefPubMed
22.
go back to reference Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH: Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant. 2012, 27 (6): 2343-2349. 10.1093/ndt/gfr643.CrossRefPubMed Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH: Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant. 2012, 27 (6): 2343-2349. 10.1093/ndt/gfr643.CrossRefPubMed
23.
go back to reference Berden AE, Jones RB, Erasmus DD, Walsh M, Noel LH, Ferrario F, Waldherr R, Bruijn JA, Jayne DR, Bajema IM: Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol. 2012, 23 (2): 313-321. 10.1681/ASN.2011040330.CrossRefPubMed Berden AE, Jones RB, Erasmus DD, Walsh M, Noel LH, Ferrario F, Waldherr R, Bruijn JA, Jayne DR, Bajema IM: Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol. 2012, 23 (2): 313-321. 10.1681/ASN.2011040330.CrossRefPubMed
24.
go back to reference Franssen CF, Gans RO, Arends B, Hageluken C, Ter Wee PM, Gerlag PG, Hoorntje SJ: Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int. 1995, 47 (1): 193-199. 10.1038/ki.1995.23.CrossRefPubMed Franssen CF, Gans RO, Arends B, Hageluken C, Ter Wee PM, Gerlag PG, Hoorntje SJ: Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int. 1995, 47 (1): 193-199. 10.1038/ki.1995.23.CrossRefPubMed
25.
go back to reference Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC: Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002, 61 (1): 80-89. 10.1046/j.1523-1755.2002.00089.x.CrossRefPubMed Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC: Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002, 61 (1): 80-89. 10.1046/j.1523-1755.2002.00089.x.CrossRefPubMed
26.
go back to reference Nachman PH, Hogan SL, Jennette JC, Falk RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996, 7 (1): 33-39.PubMed Nachman PH, Hogan SL, Jennette JC, Falk RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996, 7 (1): 33-39.PubMed
27.
go back to reference Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, Van Paassen P: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363 (3): 211-220. 10.1056/NEJMoa0909169.CrossRefPubMed Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, Van Paassen P: Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363 (3): 211-220. 10.1056/NEJMoa0909169.CrossRefPubMed
28.
go back to reference Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD: ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004, 19 (6): 1403-1411. 10.1093/ndt/gfh161.CrossRefPubMed Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD: ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004, 19 (6): 1403-1411. 10.1093/ndt/gfh161.CrossRefPubMed
29.
go back to reference Hilhorst M, Wilde B, Van Paassen P, Winkens B, Van Breda Vriesman P, Cohen Tervaert JW: Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant. 2013, 28 (2): 373-379. 10.1093/ndt/gfs428. Feb. doi: 10.1093CrossRefPubMed Hilhorst M, Wilde B, Van Paassen P, Winkens B, Van Breda Vriesman P, Cohen Tervaert JW: Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant. 2013, 28 (2): 373-379. 10.1093/ndt/gfs428. Feb. doi: 10.1093CrossRefPubMed
30.
go back to reference Hilhorst M, Wilde B, Van Breda VP, Van Paassen P, Cohen Tervaert JW: Estimating Renal Survival Using the ANCA-Associated GN Classification. J Am Soc Nephrol. 2013, 24 (9): 1371-1375. 10.1681/ASN.2012090912.CrossRefPubMedPubMedCentral Hilhorst M, Wilde B, Van Breda VP, Van Paassen P, Cohen Tervaert JW: Estimating Renal Survival Using the ANCA-Associated GN Classification. J Am Soc Nephrol. 2013, 24 (9): 1371-1375. 10.1681/ASN.2012090912.CrossRefPubMedPubMedCentral
Metadata
Title
Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome
Authors
Carla L Ellis
Rebecca L Manno
John P Havill
Lorraine C Racusen
Duvuru Geetha
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-210

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue